According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM) is $0.22 M. In 2022 the company made a revenue of $0.22 M a decrease over the years 2021 revenue that were of $0.22 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.22 M | 0% |
2022 | $0.22 M | 0% |
2021 | $0.22 M | -2.16% |
2020 | $0.23 M | -89.42% |
2019 | $2.18 M | 77.77% |
2018 | $1.22 M | 56.04% |
2017 | $0.78 M | -85.81% |
2016 | $5.54 M | -51.59% |
2015 | $11.45 M | 1332% |
2014 | $0.8 M | -83.17% |
2013 | $4.75 M | -89.71% |
2012 | $46.19 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Baxter BAX | $14.94 B | 6,614,501.77% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $25.72 M | 11,284.51% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $75.76 M | 33,426.11% | ๐บ๐ธ USA |
Cleveland BioLabs
CBLI | $0.63 M | 179.58% | ๐บ๐ธ USA |
Array Technologies ARRY | $1.57 B | 697,488.94% | ๐บ๐ธ USA |